LIFU AUD - Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
Study Basics
Are you over the age of 18 and diagnosed with Alcohol Use Disorder (AUD)? If so, you may be eligible to participate in a feasibility research study to determine if Low-Intensity Focused Ultrasound (LIFU) can be used to change brain activity in a brain region related to alcohol craving.
Study Purpose
The study team is investigating if Low-Intensity Focused Ultrasound (LIFU) can be used to suppress cravings in alcohol use disorder.
Once screening is completed, study participants will undergo two LIFU treatment sessions over two study visits. In one of these sessions, participants will receive LIFU treatment to a key brain area involved in alcohol craving. This brain region is called the ventral striatum. In the other session, you will receive LIFU treatment to a different brain area involved in sensation. This is called ventroposterolateral thalamus and is not usually associated with craving or alcohol use disorder. This is used as a control treatment. You will not be told which treatment you will receive during each of these sessions to control for placebo effects.
Could this study be right for you?
Eligible participants are:
- Age 18 or older
- Diagnosed with Alcohol Use Disorder (AUD)
What participants can expect
This study will require an in-person visit to the research site once a week for five weeks, totaling five study visits. During the first visit, study participants will meet with the study team, review the consent documentation, and complete screening procedures. The next three visits involve brain scans and/or LIFU treatment. The final visit will be follow-up procedures.
IRB: 24-41884 - Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
Contact the Research Team if you are interested in participating
Study Personnel
Khaled Moussawi, MD, PhD
Principal Investigator
Associate Professor in Residence in the departments of Neurology and Psychiatry at UCSF with extensive experience in substance use disorders and neuromodulation. Dr. Moussawi is board-certified by the American Board of Psychiatry and Neurology.
Ru Zhang, PhD
Assistant Researcher
Ru Zhang is an assistant professional researcher with a background in cognitive psychology and neuroscience. She received her PhD in mathematical and computational cognitive science from Purdue University.
Kelly Kadlec, PhD
Postdoctoral Scholar
Kelly Kadlec is a postdoctoral researcher with a background in electrical engineering and neuroscience. She received her PhD in Neurobiology from Caltech.
Brooke Staveland, PhD
Postdoctoral Scholar
Brooke Staveland is a postdoctoral researcher with a background in clinical psychology and neuroscience. She received her PhD in Neuroscience from UC Berkeley.
Sarah Li, PhD
Postdoctoral Scholar
Sarah Li is a postdoctoral researcher with a background in biomedical engineering and ultrasound tongue imaging, along with an interest in non-invasive measurement for neuropsychiatric disorders. She received her PhD in Biomedical Engineering from the University of Cincinnati.
Sierra Brandts, BS
Clinical Research Coordinator
Sierra Brandts is a Clinical Research Coordinator with a background in neuromodulation and addiction research. She received her BS in Neuroscience from Sewanee: The University of the South.
Emme Chen, BS
Jr. Research Specialist
Emme Chen is a Jr. Research Specialist with a clinical background in addiction medicine. She received her degree in Biopsychology from UC Santa Barbara.